Zilidor

Paricalcitol is a synthetic vitamin D analog used to manage secondary hyperparathyroidism in chronic kidney disease. This intravenous form helps regulate calcium and phosphorus levels. It is prescribed under medical supervision for patients on dialysis. Commonly searched as paricalcitol injection uses or paricalcitol iv for secondary hyperparathyroidism.

Paricalcitol is primarily used to treat secondary hyperparathyroidism in adults with chronic kidney disease who are on dialysis. It works by reducing elevated parathyroid hormone levels that can lead to bone and mineral disorders. Patients often ask what is paricalcitol used for in kidney disease management. It is also used off-label in certain cases of vitamin D deficiency related to kidney impairment.

Paricalcitol helps normalize calcium and phosphorus balance in the body when used as directed. Patients may notice improved bone health markers over time with consistent use. The medication works gradually to support kidney-related mineral metabolism. Some users report better energy levels as parathyroid hormone levels stabilize.

Paricalcitol should only be used under the guidance of a healthcare professional. Regular blood tests are typically required to monitor calcium, phosphorus, and parathyroid hormone levels. Patients with a history of high calcium levels should use this medication with caution. Always inform your doctor about all current medications and health conditions before starting paricalcitol.

Paricalcitol may interact with other medications that affect calcium levels, such as calcium supplements or thiazide diuretics. Strong CYP3A inhibitors can increase paricalcitol levels, while CYP3A inducers may reduce its effectiveness. Cholestyramine and certain antacids may also interfere with absorption. Always discuss all medications with your healthcare provider before combining them with paricalcitol.